miércoles, 11 de marzo de 2026

Engineered immune cells target Alzheimer’s disease protein

Engineered immune cells target Alzheimer’s disease protein At a Glance Scientists designed a T cell that reduced signs of disease in the brains of a mouse model for Alzheimer’s disease. With further development, this type of immunotherapy could one day help treat Alzheimer’s disease and some other brain disorders. https://www.nih.gov/news-events/nih-research-matters/engineered-immune-cells-target-alzheimers-disease-protein

No hay comentarios:

Publicar un comentario